.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Argus Health
Chinese Patent Office
Moodys
Novartis
US Army
Mallinckrodt
Chubb
Daiichi Sankyo
Federal Trade Commission

Generated: June 26, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: rufinamide

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai Inc
BANZEL
rufinamide
TABLET;ORAL021911NDAEisai Inc.62856-582-52120 TABLET, FILM COATED in 1 BOTTLE (62856-582-52)
Eisai Inc
BANZEL
rufinamide
TABLET;ORAL021911NDAEisai Inc.62856-583-52120 TABLET, FILM COATED in 1 BOTTLE (62856-583-52)
Eisai Inc
BANZEL
rufinamide
SUSPENSION;ORAL201367NDAEisai Inc.62856-584-461 BOTTLE in 1 CARTON (62856-584-46) > 460 mL in 1 BOTTLE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Medtronic
AstraZeneca
Colorcon
McKinsey
Moodys
QuintilesIMS
McKesson
Daiichi Sankyo

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot